Metabolic dysfunction-associated steatotic liver disease or MASLD (renamed from NAFLD in June 2023) encompasses patients who have hepatic steatosis and have at least one of five cardiometabolic risk factors.
Leveraging InSphero’s market-leading 3D InSight™ MASH model, our 3D In Vitro MASLD model offers equivalent advantages for fatty liver disease research. Experience a high-quality, scalable, and human-relevant 3D cell culture disease model that generates precise insights and facilitates efficient research throughput. Rely on our expertise in creating primary-cell spheroid models and inducing specific disease phenotypes, enabling us to tailor solutions to your needs – fast and efficient for early-stage decision-making.
Discover a top-tier 3D cell culture disease model that is scalable and closely mimics human biology, providing accurate insights for enhanced efficiency. This advanced 3D in vitro MASLD model streamlines your research process, ensuring precise and effective decisions early in the drug development.
As complex as necessary and as simple as possible – our research credo at work. Based on co-culturing fatty liver disease relevant primary cells, our model accurately mimics MASLD
Our MASLD model is great for mechanistic research, as well as for automated screening, compatible with all platforms
3D InSight™ MASLD models are available in multi-donor form or based on single donors including metabolically relevant SNPs (e.g., PNPLA3, HSD17B13)
10x faster: that is the time you save going <i>in vitro</i> instead of animal models. Faster data, more insights, quicker iterations to find and assess your compounds
Primary human hepatocytes (PHHs), Kupffer cells, and liver endothelial cells (LECs)
Using an optimized treatment with free fatty acids and elevated sugar concentration
Multiple compound addition steps to mimic regular intake
Quantification of lipid content using biochemical or advanced imaging assays
Fill in form below to contact our 3D in vitro experts
Get the latest news on 3D in vitro research
Fill in the form below to view this resource